These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35199372)

  • 1. Major disparities in patient-reported adherence compared to objective assessment of adherence using mass spectrometry: A prospective study in a tertiary-referral hypertension clinic.
    Curneen JMG; Rabbitt L; Browne D; O'Donoghue DF; Alansari Y; Harhen B; Ní Ghríofa A; Ferguson J; McEvoy JW; Lappin D; Finn DP; O'Shea PM; Dennedy MC
    Br J Clin Pharmacol; 2023 Jul; 89(7):1948-1955. PubMed ID: 35199372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive Medication Adherence and Confirmation of True Refractory Hypertension.
    Siddiqui M; Judd EK; Dudenbostel T; Gupta P; Tomaszewski M; Patel P; Oparil S; Calhoun DA
    Hypertension; 2020 Feb; 75(2):510-515. PubMed ID: 31813346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for non-adherence to antihypertensive treatment as a part of the diagnostic pathway to renal denervation.
    Patel P; Gupta PK; White CM; Stanley AG; Williams B; Tomaszewski M
    J Hum Hypertens; 2016 Jun; 30(6):368-73. PubMed ID: 26446393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring adherence to antihypertensive medication using an objective test in older adults attending primary care: cross-sectional study.
    Sheppard JP; Albasri A; Gupta P; Patel P; Khunti K; Martin U; McManus RJ; Hobbs FDR
    J Hum Hypertens; 2022 Dec; 36(12):1106-1112. PubMed ID: 34876657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis.
    Tomaszewski M; White C; Patel P; Masca N; Damani R; Hepworth J; Samani NJ; Gupta P; Madira W; Stanley A; Williams B
    Heart; 2014 Jun; 100(11):855-61. PubMed ID: 24694797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine urinary detection of antihypertensive drugs for systematic evaluation of adherence to treatment in hypertensive patients.
    Hamdidouche I; Jullien V; Boutouyrie P; Billaud E; Azizi M; Laurent S
    J Hypertens; 2017 Sep; 35(9):1891-1898. PubMed ID: 28505066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring adherence to therapy in apparent treatment-resistant hypertension: a feasibility study in Irish primary care.
    Hayes P; Casey M; Glynn LG; Molloy GJ; Durand H; O'Brien E; Dolan E; Das K; Newell J; Finn D; Harhen B; Conneely A; Murphy AW
    Br J Gen Pract; 2019 Sep; 69(686):e621-e628. PubMed ID: 31358495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistant hypertension? Assessment of adherence by toxicological urine analysis.
    Jung O; Gechter JL; Wunder C; Paulke A; Bartel C; Geiger H; Toennes SW
    J Hypertens; 2013 Apr; 31(4):766-74. PubMed ID: 23337469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to Antihypertensive Drugs Assessed by Hyphenated High-Resolution Mass Spectrometry Analysis of Oral Fluids.
    Lauder L; Ewen S; Kunz M; Richter LHJ; Jacobs CM; Kindermann I; Böhm M; Meyer MR; Mahfoud F
    J Am Heart Assoc; 2020 Jul; 9(14):e014180. PubMed ID: 32633188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonadherence to antihypertensive medications is related to pill burden in apparent treatment-resistant hypertensive individuals.
    Lawson AJ; Hameed MA; Brown R; Cappuccio FP; George S; Hinton T; Kapil V; Lenart J; Lobo MD; Martin U; Menon M; Nightingale A; Rylance PB; Webb DJ; Dasgupta I
    J Hypertens; 2020 Jun; 38(6):1165-1173. PubMed ID: 32371807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Masked Uncontrolled Hypertension Is Not Attributable to Medication Nonadherence.
    Siddiqui M; Judd EK; Dudenbostel T; Zhang B; Gupta P; Tomaszewski M; Patel P; Oparil S; Calhoun DA
    Hypertension; 2019 Sep; 74(3):652-659. PubMed ID: 31327263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct assessment of adherence and drug interactions in patients with hypertensive crisis-A cross-sectional study in the Emergency Department.
    Wallbach M; Lach N; Stock J; Hiller H; Mavropoulou E; Chavanon ML; Neurath H; Blaschke S; Lowin E; Herrmann-Lingen C; Müller GA; Koziolek MJ
    J Clin Hypertens (Greenwich); 2019 Jan; 21(1):55-63. PubMed ID: 30515967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis.
    Ewen S; Meyer MR; Cremers B; Laufs U; Helfer AG; Linz D; Kindermann I; Ukena C; Burnier M; Wagenpfeil S; Maurer HH; Böhm M; Mahfoud F
    Clin Res Cardiol; 2015 Dec; 104(12):1097-105. PubMed ID: 26306594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying adherence to antihypertensive medication for chronic hypertension during pregnancy.
    Webster LM; Reed K; Myers JE; Burns A; Gupta P; Patel P; Wiesender C; Seed PT; Nelson-Piercy C; Chappell LC
    Pregnancy Hypertens; 2019 Jul; 17():12-14. PubMed ID: 31487627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication adherence among patients with apparent treatment-resistant hypertension: systematic review and meta-analysis.
    Durand H; Hayes P; Morrissey EC; Newell J; Casey M; Murphy AW; Molloy GJ
    J Hypertens; 2017 Dec; 35(12):2346-2357. PubMed ID: 28777133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing.
    Lane D; Lawson A; Burns A; Azizi M; Burnier M; Jones DJL; Kably B; Khunti K; Kreutz R; Patel P; Persu A; Spiering W; Toennes SW; Tomaszewski M; Williams B; Gupta P; Dasgupta I;
    Hypertension; 2022 Jan; 79(1):12-23. PubMed ID: 34739765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonadherence to antihypertensive medications amongst patients with uncontrolled hypertension: A retrospective study.
    Kulkarni S; Rao R; Goodman JDH; Connolly K; O'Shaughnessy KM
    Medicine (Baltimore); 2021 Apr; 100(14):e24654. PubMed ID: 33832064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Pharmacy Refill Data With Chemical Adherence Testing in Assessing Medication Nonadherence in a Safety Net Hospital Setting.
    Osula D; Wu B; Schesing K; Das SR; Moss E; Alvarez K; Clark C; Halm EA; Brown NJ; Vongpatanasin W
    J Am Heart Assoc; 2022 Oct; 11(19):e027099. PubMed ID: 36193931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel 'Dilute-and-Shoot' Liquid Chromatography-Tandem Mass Spectrometry Method for the Screening of Antihypertensive Drugs in Urine.
    Lawson AJ; Shipman KE; George S; Dasgupta I
    J Anal Toxicol; 2016; 40(1):17-27. PubMed ID: 26333988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonadherence by Serum Drug Analyses in Resistant Hypertension: 7-Year Follow-Up of Patients Considered Adherent by Directly Observed Therapy.
    Halvorsen LV; Bergland OU; Søraas CL; Larstorp ACK; Hjørnholm U; Kjær VN; Kringen MK; Clasen PE; Haldsrud R; Kjeldsen SE; Rostrup M; Fadl Elmula FEM; Opdal MS; Høieggen A
    J Am Heart Assoc; 2022 Sep; 11(18):e025879. PubMed ID: 36073648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.